Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation

(2014) Pilar Gallego et al.   AMERICAN JOURNAL OF MEDICINE

Relationship of the SAMe-TT 2 R 2 Score to Poor-Quality Anticoagulation, Stroke, Clinically Relevant Bleeding, and Mortality in Patients With Atrial Fibrillation

(2014) Gregory Y.H. Lip et al.   CHEST

A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin

(2014) Daniela Poli et al.   Internal and Emergency Medicine

Novel oral anticoagulants in non-valvular atrial fibrillation

(2013) Tatjana S. Potpara et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

General mechanisms of coagulation and targets of anticoagulants (Section I)

(2013) Steen Husted et al.   THROMBOSIS AND HAEMOSTASIS

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice

(2012) Gregory Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor

(2012) A. G. G. Turpie et al.   THROMBOSIS AND HAEMOSTASIS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)

(2010) A. J. ROSE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

(2008) Stuart J. Connolly et al.   CIRCULATION

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.